| Intrinsic Valuation of: DXCM | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 2 | Market Cap | $24B | |||||
| 2021 | - | - (-) | P/E Ratio | 26 | Total Asset | $6B | |||||
| 2022 | $305M | - (-) | Net Income | $836M | Total Debt | $1B | |||||
| 2023 | $512M | 68.0% (35.0%) | EBITDA | $1B | Total Liab | $4B | |||||
| 2024 | $631M | 23.2% (10.7%) | Opr Margin | 19.56 | Debt/Equity | 0.45 | |||||
| 2025 | $1B | 70.8% (47.8%) | PreTax Margin | 19.17 | BV/Share | 7 | |||||
| 5Y Average FCF | $631M | 15.0% (31.2%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.48% | Historical US Bond Yield: | 4.40% | ||||||||
| Discount Rate (WACC): | 10.75% | Current US Bond Yield: | 3.48% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (15.0%) | ||||||||||
| 2026 | $1B | MBG Intrinsic Value | $21 | ||||||||
| 2027 | $1B | ||||||||||
| 2028 | $1B | ||||||||||
| 2029 | $1B | ||||||||||
| 2030 | $2B | ||||||||||
| 2031 | $2B | ||||||||||
| Terminal Value | $19B | Net Worth/Share | $7 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | $16B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | $918M | $41 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | $1B | WACC | 8.8% | 49 | 51 | 55 | 58 | 63 | |||
| Equity Value | $16B | 9.8% | 43 | 45 | 47 | 49 | 52 | ||||
| Shares Outstanding | 385,872,977 | 10.8% | 38 | 39 | 41 | 43 | 45 | ||||
| 11.8% | 34 | 35 | 36 | 38 | 39 | ||||||
| DCF Intrinsic Value | $41 | 12.8% | 31 | 32 | 33 | 34 | 35 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||